ABSTRACT
OBJECTIVE: To describe the prevalence of diabetes and major cardiovascular risk factors in the adult population of the autonomous region of Madrid (Spain). MATERIAL AND METHOD: A population-based cross-sectional study was carried out in 2007. A random sample of the population aged 30-74 years old was selected. A fixed sample size per age stratum was assigned, weighted by the real age-specific distribution of the population of the autonomous region of Madrid. An epidemiological survey was conducted by telephone. Subsequently, physical examination was performed and a fasting blood sample was taken in the health center for glucose, cholesterol and lipid fraction determinations. RESULTS: We included 2268 people with a mean age of 48.3 years old (52% women). The response rate was 56.4%. Diabetes was found in 8.1% (95%CI: 7.0-8.9) of the adult population and impaired fasting glucose was found in 5.9% (95%CI: 4.8-6.1). The prevalence of risk factors was as follows: hypertension in 29.3% (95%CI: 27.3-31.5), hypercholesterolemia in 23.3% (95%CI: 21.8-26.1), overweight grade II in 22.8% (20.8-25.0), obesity in 21.7% (95%CI: 19.8-23.6), and central obesity in 23.9% (95%CI: 21.8-26.1). A total of 85.5% (95%CI: 83.1-87.1) were sedentary in their leisure time and 28.4% (95%CI: 26.3-30.3) were smokers. CONCLUSIONS: The prevalence of diabetes in the autonomous region of Madrid is intermediate in relation to other regions of Spain. Cardiovascular risk factors are highly prevalent, and are higher in men than in women. Overweight and obesity, affecting 4.5 out of every 10 adults, should be considered a priority for health interventions in cardiovascular disease prevention.
Subject(s)
Cardiovascular Diseases/epidemiology , Diabetes Mellitus/epidemiology , Adult , Aged , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Prevalence , Risk Factors , Spain , Urban HealthABSTRACT
Primary hyperparathyroidism is a common endocrinological disease and most cases are asymptomatic. We report the case of a patient with primary hyperparathyroidism and symptomatic bone lesions. The possibility of different etiologies (adenoma vs carcinoma) according to the clinical manifestations and treatment are also discussed.
Subject(s)
Hyperparathyroidism, Primary/diagnosis , Osteitis Fibrosa Cystica/etiology , Adenoma/complications , Adenoma/diagnosis , Adenoma/surgery , Adult , Fractures, Spontaneous/etiology , Humans , Humeral Fractures/etiology , Hypercalcemia/diagnosis , Hypercalcemia/etiology , Hyperparathyroidism, Primary/blood , Hyperparathyroidism, Primary/complications , Hypocalcemia/etiology , Magnetic Resonance Imaging , Male , Osteitis Fibrosa Cystica/diagnostic imaging , Osteolysis/diagnostic imaging , Osteolysis/etiology , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/diagnosis , Parathyroid Neoplasms/surgery , Parathyroidectomy , Postoperative Complications/etiology , RadiographyABSTRACT
BACKGROUND AND OBJECTIVE: To assess the prevalence of metabolic syndrome (MS) and cardiovascular risk factors in patients with established cardiovascular disease (CVD). PATIENTS AND METHOD: Epidemiologic, cross-sectional, multicentre and national study. 1,342 evaluable patients were recruited by 95 physicians of primary care, cardiology, endocrinology and internal medicine. All patients had confirmed diagnosis of CVD (myocardial infarction, coronary disease, ischaemic cerebrovascular disease and/or peripheral vascular disease) and analytical data for the study of MS according to Adult Treatment Panel-III (MS identified as presence of at least 3 components: abdominal obesity, triglycerides > or = 150 mg/dl, high density lipoproteins-cholesterol < 40 mg/dl in men and < 50 mg/dl in women, blood pressure > 130/85 mmHg and fasting glucose > 110 mg/dl). RESULTS: 37% (n = 497) of patients presented MS, with a higher prevalence among women (51.5% versus 31.8%) (chi2 test, p < 0.0001). 58% of patients had abdominal obesity, 50.4% hyperglycemia, 39.7% hypertriglyceridemia, 34.4% low values of high density lipoproteins-cholesterol and 28% high blood pressure. Abdominal obesity (86.7%) and hyperglycemia (82.7%) were the most prevalent components among patients with MS. Previous ischaemic cerebrovascular disease was more prevalent among patients with MS (22.3% versus 17.5%) (chi2 test, p < 0.05), as well as family history of hypertension, diabetes, ischaemic cardiopathy and ischaemic cerebrovascular disease (49.1%, 46.3%, 41.1% and 27.5%) (chi2 test, p < 0.05). Patients with MS showed a higher probability of suffering cardiac event in the next 10 years (25.3% vs. 17.4%). CONCLUSIONS: The prevalence of MS among Spanish population with CVD is high, specially among women.
